Cell-Free DNA-Methylation-Based Methods and Applications in Oncology
Liquid biopsy based on cell-free DNA (cfDNA) enables non-invasive dynamic assessment of disease status in patients with cancer, both in the early and advanced settings. The analysis of DNA-methylation (DNAm) from cfDNA samples holds great promise due to the intrinsic characteristics of DNAm being mo...
Main Authors: | Francesca Galardi, Francesca De Luca, Dario Romagnoli, Chiara Biagioni, Erica Moretti, Laura Biganzoli, Angelo Di Leo, Ilenia Migliaccio, Luca Malorni, Matteo Benelli |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-12-01
|
Series: | Biomolecules |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-273X/10/12/1677 |
Similar Items
-
Editorial: Liquid Biopsy as a Tool for Precision Oncology: New Challenges to Assess Clinical Response
by: Gloria Ravegnini, et al.
Published: (2020-10-01) -
Promoter Methylation of Selected Genes in Non-Small-Cell Lung Cancer Patients and Cell Lines
by: Victoria Sarne, et al.
Published: (2020-06-01) -
Assessment of Circulating Nucleic Acids in Cancer: From Current Status to Future Perspectives and Potential Clinical Applications
by: Gabriella Cirmena, et al.
Published: (2021-07-01) -
Editorial: Exploiting DNA Damage Response in the Era of Precision Oncology
by: Yitzhak Zimmer, et al.
Published: (2020-10-01) -
DNA Methylation Cancer Biomarkers: Translation to the Clinic
by: Warwick J. Locke, et al.
Published: (2019-11-01)